AI in Medicine News ・ ⚖️ Device approvals and regulation

Why Agentic AI Is Not Yet FDA Approved

Drug Topics 🔗 Share link 10/27 13:00 UTC 🔗 Share link Stanford Scholars Respond to FDA on Regulating Gen-AI Medical Devices — Freeman Spogli Institute for International Studies 🔗 Share link 10/26 12:00 UTC 🔗 Share link Heartflow sues AI rival Elucid over alleged IP violations — Cardiovascular Business 🔗 Share link 10/26 19:38 UTC 🔗 Share link AI medical device regulation after approval: What NHS trusts should set up now — Health Tech World · 10/27 08:08 UTC

The risks and behavior of autonomous, agentic AI in health care remain relatively uncharted, so regulators such as the FDA are taking a cautious approach to clearance. The FDA is soliciting industry feedback on evaluation frameworks. The article says rigorous, standardized oversight is essential for patient safety and clinical reliability before these tools enter real-world practice.

Read the original (Drug Topics 🔗 Share link 10/27 13:00 UTC 🔗 Share link Stanford Scholars Respond to FDA on Regulating Gen-AI Medical Devices — Freeman Spogli Institute for International Studies 🔗 Share link 10/26 12:00 UTC 🔗 Share link Heartflow sues AI rival Elucid over alleged IP violations — Cardiovascular Business 🔗 Share link 10/26 19:38 UTC 🔗 Share link AI medical device regulation after approval: What NHS trusts should set up now — Health Tech World)

See it in the digest → ・ See this issue →